{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Uterine+Cervix+Cancer&page=22", "query": { "condition": "Uterine Cervix Cancer", "page": 22 }, "page_size": 10 }, "pagination": { "page": 22, "page_size": 10, "total_count": 833, "total_pages": 84, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Uterine+Cervix+Cancer&page=23&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Uterine+Cervix+Cancer&page=21&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T15:34:09.938Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06457997", "title": "A Study of PHN-010 in Patients With Advanced Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Cancer", "Colon Cancer", "Endometrial Cancer", "Ovarian Cancer", "Cervical Cancer", "Advanced Solid Tumor", "Advanced Cancer" ], "interventions": [ { "name": "PHN-010", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pheon Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2024-07-01", "completion_date": "2025-09-11", "has_results": false, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 8, "location_summary": "Orlando, Florida • Boston, Massachusetts • New York, New York + 5 more", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06457997" }, { "nct_id": "NCT07223424", "title": "Patient Preference for Subcutaneous vs. Intravenous Immune Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Cell Carcinoma", "Non Small Cell Lung Cancer", "Melanoma", "Colo-rectal Cancer (dMMR/MSI-H CRC)", "Hepatocellular Carcinoma", "Ulcerative Colitis", "Esophageal Cancer", "Squamous Cell Carcinoma", "Gastric/GEJ", "Cervical Cancer", "Gastro-Esophageal Adenocarcinoma", "Esophageal Adenocarcinoma" ], "interventions": [ { "name": "nivolumab", "type": "DRUG" }, { "name": "pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Diwakar Davar", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 880, "start_date": "2025-11-04", "completion_date": "2030-11-30", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223424" }, { "nct_id": "NCT05975593", "title": "MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Locally Advanced Cervical Carcinoma", "Locally Advanced Cervical Cancer", "Locally Advanced Pancreas Cancer", "Locally Advanced Pancreatic Carcinoma", "Locally Advanced Pancreatic Cancer", "Cervical Cancer", "Pancreas Cancer", "Pancreatic Cancer", "Cancer of the Cervix", "Cancer of the Pancreas" ], "interventions": [ { "name": "Tumor collection via biopsy", "type": "OTHER" }, { "name": "Blood collection", "type": "OTHER" }, { "name": "Diffusion basis spectrum imaging (DBSI) magnetic resonance imaging (MRI)", "type": "DEVICE" } ], "intervention_types": [ "OTHER", "DEVICE" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2024-01-11", "completion_date": "2032-12-31", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05975593" }, { "nct_id": "NCT04551950", "title": "Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cervical Cancer" ], "interventions": [ { "name": "M7824", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Radiotherapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "EMD Serono Research & Development Institute, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 25, "start_date": "2020-10-19", "completion_date": "2022-06-30", "has_results": true, "last_update_posted_date": "2024-03-08", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 5, "location_summary": "Stanford, California • Augusta, Georgia • Henderson, Nevada + 2 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Henderson", "state": "Nevada" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04551950" }, { "nct_id": "NCT03133286", "title": "Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Radiation Therapy", "Cancer", "Cancer of Anus", "Cancer of Bladder", "Cancer of Cervix", "Cancer of Colon", "Cancer of Rectum", "Cancer of Esophagus", "Cancer of Gallbladder", "Cancer of Liver", "Cancer of Ovary", "Cancer of Pancreas", "Cancer of Prostate", "Cancer of Kidney and Renal Pelvis", "Cancer of Stomach", "Cancer of Testis", "Cancer of Uterus", "Cancer of Uterus and Cervix", "Cancer of Kidney" ], "interventions": [], "intervention_types": [], "sponsor": "DxTerity Diagnostics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2017-04-06", "completion_date": "2020-02-25", "has_results": false, "last_update_posted_date": "2024-08-07", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 4, "location_summary": "Compton, California • Bradenton, Florida • Fort Myers, Florida + 1 more", "locations": [ { "city": "Compton", "state": "California" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Plantation", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03133286" }, { "nct_id": "NCT02512835", "title": "Understanding the Value of Community Vital Signs in Primary Care", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colon Cancer", "Breast Cancer", "Cervical Cancer", "Prostate Cancer", "Cardiovascular Disease" ], "interventions": [ { "name": "Community vital signs", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 120, "start_date": "2015-10", "completion_date": "2016-11-01", "has_results": false, "last_update_posted_date": "2018-02-28", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 2, "location_summary": "Fairfax, Virginia • Richmond, Virginia", "locations": [ { "city": "Fairfax", "state": "Virginia" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02512835" }, { "nct_id": "NCT00083213", "title": "Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "ziv-aflibercept", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 25, "start_date": "2004-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-06-03", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00083213" }, { "nct_id": "NCT04219904", "title": "PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Stage IA Cervical Cancer", "Stage IA1 Cervical Cancer", "Stage IA2 Cervical Cancer", "Stage IB Cervical Cancer", "Stage IB1 Cervical Cancer", "Stage IB2 Cervical Cancer", "Stage IB3 Cervical Cancer" ], "interventions": [ { "name": "Fludeoxyglucose F-18", "type": "OTHER" }, { "name": "Gadobutrol", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "DRUG", "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 25, "start_date": "2018-09-07", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04219904" }, { "nct_id": "NCT01908504", "title": "Adaptive Pet Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Head and Neck Cancers", "Lung and Esophagus Cancers", "Anal, Cervix, Vulvar, Vaginal, and Endometrium Cancers" ], "interventions": [ { "name": "PET-CT", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 271, "start_date": "2012-01", "completion_date": "2016-09", "has_results": false, "last_update_posted_date": "2023-04-26", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01908504" }, { "nct_id": "NCT01525433", "title": "Cervical Cancer Screening Among Hispanic Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Cancer" ], "interventions": [ { "name": "DVD", "type": "BEHAVIORAL" }, { "name": "Promotora", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "64 Years", "sex": "FEMALE", "summary": "21 Years to 64 Years · Female only" }, "enrollment_count": 451, "start_date": "2011-09", "completion_date": "2018-07-17", "has_results": false, "last_update_posted_date": "2018-11-13", "last_synced_at": "2026-10-15T15:34:09.938Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525433" } ] }